A Book Should Be Well Digested –

Dec. 17, 2018 – Writing from Britain, Dr. Ben Goldacre echoes Angell’s concerns, charging in “Bad Pharma” that the worst misbehavior in the pharmaceutical industry actually occurs not when prescription drugs are being burnished for market, but far earlier in their development. Lackluster compounds are evaluated in ways guaranteed to make them look good, Goldacre writes, then prettied up even further with distorted claims of efficacy. While “bad behavior in marketing departments is unpleasant,” he concludes, the real scientific outrage and the big public danger lie in uniformly dubious practices of drug development.

Full Story @ NYTimes.com


Read the weekly Addiction Recovery eBulletin

For Email Newsletters you can trust.